Journal of Clinical Apheresis

Papers
(The median citation count of Journal of Clinical Apheresis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Mobilization with high‐dose granulocyte colony‐stimulating factor alone at 12 μg/kg twice a day in high‐risk pediatric patients: A retrospective analysis of the experience in a single center215
19
Issue Information18
18
Role of automated red blood cell exchange in the treatment of aluminum phosphide poisoning: A case report and review of the literature16
Single center experience of therapeutic plasma exchange in a resource‐constrained setting: A study of trends in scope and complications14
Analysis of responses of the health care workers recovered from COVID‐19 on convalescent plasma donation by apheresis: A single‐center survey study14
13
Issue Information12
Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO‐incompatible hematopoietic stem cell transplant11
A validation and modification of PLASMIC score by adjusting the criteria of mean corpuscular volume and international normalized ratio10
Refractory vaccine‐induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE)10
Patients with hereditary hemochromatosis reach safe range of transferrin saturation sooner with erythrocytaphereses than with phlebotomies10
Algorithm‐based selection of automated red blood cell exchange procedure goals reduces blood utilization in chronically transfused adults with sickle cell disease9
Impact of saline infusion as replacement fluid at donor plasmapheresis9
The safety and performance of the Spectra Optia apheresis system platelet depletion protocol in patients with elevated platelet counts9
Therapeutic plasma exchange in gastric signet ring cell carcinoma presenting as microangiopathic hemolytic anemia: A rare case report9
8
Impact of saline infusion and citrate infusion rate during donor plasmapheresis8
Therapeutic plasma exchange for multiorgan dysfunction among critically ill pediatric patients with leukemia: A single‐institutional experience7
Issue Information7
Issue Information7
Addition of plerixafor in poorly mobilized allogeneic stem cell donors7
Writing manuscripts for peer review7
Issue Information7
Issue Information7
No increase in anti‐A isohemagglutinin titer after SARS‐CoV‐2 infection: A retrospective cohort analysis of group O apheresis platelet donors7
7
Immunity in the balance: Fatal disseminated adenovirus infection in a patient undergoing plasma exchange and immunosuppressive chemotherapy for anti‐glomerular basement membrane disease6
6
A Saudi multicenter experience on therapeutic plasma exchange for patients with thrombotic thrombocytopenic purpura: A call for national registry6
I‐JAMM (II)—Therapeutic Apheresis Practices in Preconditioning of ABO‐Incompatible Kidney and Liver Transplants in India5
CD34+ cell yield among healthy donors: Large‐scale model development and validation5
Early is superior to late plasma exchange for severe multisystem inflammatory syndrome in children5
A retrospective study for association between post‐transfusion hemoglobin S level and pre‐transfusion hemoglobin S level at the next scheduled transfusion5
What's in a Name: Your PLEX or PEX Is Our TPE5
Central venous catheters are associated with thrombosis among adult inpatients undergoing therapeutic plasma exchange5
The use of therapeutic plasma exchange as adjunctive therapy in the treatment of coronavirus disease 2019: A critical appraisal of the current evidence5
Therapeutic plasma exchange is a safe and effective bridge therapy in patients with alcohol‐associated ACLF not having immediate prospects for liver transplantation—A case‐control, pilot st4
Effectiveness of leukapheresis on early survival in acute myeloid leukemia: An observational propensity score matching cohort study4
Rheopheresis for severe peripheral arterial disease in hemodialysis patients: A clinical series4
4
Telapheresis: One institution's experience4
Apheresis practice patterns in the United States of America: Analysis of a market claims database4
Large volume plasmapheresis using a single‐use immunoadsorption column: A cost‐effective approach for desensitization in ABO‐incompatible liver transplant4
Therapeutic plasma exchange for mechanical red cell hemolysis: A case series4
Apheresis practice variation during the COVID‐19 pandemic: Results of a survey4
Mobilized and apheresis‐collected endothelial progenitor cells with plerixafor4
Plasmapheresis compared with conventional treatment for hypertriglyceridemia‐induced acute pancreatitis: A systematic review and meta‐analysis4
Successful “on‐demand” plerixafor for autologous peripheral blood stem‐cells transplantation for relapsed/refractory germ cell tumors4
Suspected autoimmune encephalitis: A retrospective study of patients referred for therapeutic plasma exchange4
Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster‐randomized controlled trial4
The efficiency of a continuous versus an intermittent apheresis method for collection of hematopoietic progenitor stem cells: A systematic review3
Vascular access for autologous peripheral blood stem cells collection by large volume leukapheresis: Single center experience3
3
Correlation between peripheral blood automated hematopoietic progenitor cell counts and flow cytometric CD34+ cell counts differs according to diagnosis in patients undergoing au3
Therapeutic Plasma Exchange for the Symptomatic Treatment of Scleromyxedema: A Case Report and Literature Review3
Comparison of peripheral blood automated hematopoietic progenitor cell count and flow cytometric CD34+ cell count3
Donor tolerability of convalescent plasma donation3
Therapeutic plasma exchange as treatment modality in pediatric patients with neurologic and nonneurologic diseases at the Philippine Children's Medical Center: A 12‐year single center experience3
Rapid development of a de novo convalescent plasma program in response to a global pandemic: A large southeastern U.S. blood center's experience3
Therapeutic plasma exchange in adolescent and adult patients with autoimmune neuropsychiatric disorders associated with streptococcal infections3
Therapeutic plasma exchange for life‐threatening pediatric disorders3
3
Special Issue Abstracts From the American Society for Apheresis 43rd Annual Meeting May 4–6, 2022 Philadelphia, Pennsylvania3
Interest of therapeutic plasmapheresis in a chronic hemodialysis patient with severe bullous pemphigoid3
MicroRNA and granulocyte‐monocyte adsorption apheresis combotherapy after inadequate response to anti‐TNF agents in ulcerative colitis3
Safety and efficacy of peripheral blood stem cells collection in healthy children and pediatric patients with thalassemia major weighing 20 kg or less3
Extracorporeal photopheresis vs standard therapies for steroid‐refractory chronic graft‐vs‐host disease: Pharmacoeconomic assessment of hospital resource use in Spain3
Immunoadsorption and plasma exchange—Efficient treatment options for neurological autoimmune diseases3
Issue Information3
High D‐index during mobilization predicts poor mobilization ofCD34+ cells after anti‐lymphoma salvage chemotherapy3
Impact of Covid‐19 on the therapeutic plasma exchange service within the South East Asian region: Consensus recommendations and global perspectives3
An Annual Review of Important Apheresis Articles From the American Society for Apheresis Attending Physician Subcommittee3
Hematopoietic progenitor cell counting can optimize peripheral blood stem cell apheresis process2
Therapeutic plasma exchange for steroid refractory idiopathic inflammatory myopathies with interstitial lung disease2
Issue Information2
Therapeutic plasma exchange for peripheral neuropathy associated with trisulfated heparan disaccharide IgM antibodies: A case series of 17 patients2
Crude collection efficiency of CD34+ hematopoietic stem cell apheresis2
Hemoglobin S target of <50% as compared to 30% in chronic red cell exchange for secondary stroke prevention in sickle cell disease2
Feasibility, safety, and tolerability of two modalities of plasma exchange with albumin replacement to treat elderly patients with Alzheimer's disease in the AMBAR study2
Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group2
Autologous hematopoietic stem cell product contaminated with Salmonella due to occult salmonellosis in an asymptomatic donor2
Severe complications in a 25‐year‐old male after brown recluse spider bite treated by therapeutic plasma exchange: A case report and review of other case studies2
Infectious risks in patients treated with extracorporeal photopheresis for graft‐versus‐host disease: A retrospective cohort study2
COVID‐19‐associated transverse myelitis treated by therapeutic plasma exchange: A case report2
Comparison of procedure times and collection efficiencies using integrated and multistep nonintegrated procedures for extracorporeal photopheresis2
Massive bee envenomation treated by therapeutic plasma exchange2
Adsorptive cytapheresis in ulcerative colitis: A non‐pharmacological therapeutic approach revisited2
Safety and performance of theSpectraOptia apheresis system for white blood cell depletion in patients with elevated white blood cell counts2
Modifications to therapeutic plasma exchange to achieve rapid exchange on cardiopulmonary bypass prior to pediatric cardiac transplant2
Special Issue Abstracts from the American Society for Apheresis 44th Annual Meeting April 26–28, 20232
Comment on “Donor tolerability of convalescent plasma donation”2
A prospective study on tryptophan immunoadsorption in AQP4 antibody‐positive neuromyelitis optica spectrum disorders2
Evaluation of safety of using incompatible plasma for therapeutic plasma exchange during shortage of AB plasma2
Nationwide practices in the use of central venous catheters for therapeutic plasma exchange in the inpatient setting2
Recovery of Symmetrical Peripheral Gangrene of Limbs in a Patient After Performing Hemoadsorption in Septic Shock2
Are we choosing mobilization regimens for autologous stem cell transplantation in multiple myeloma wisely: A single center comparison of GCSF+/−plerixafor vs cyclophosphamide/GCSF2
Immune checkpoint inhibitor toxicity: A new indication for therapeutic plasma exchange?2
A rare case of acute cerebellitis due to enterovirus treated with therapeutic plasma exchange: Case report and review of the literature2
Real‐world evidence of heparin and citrate use in extracorporeal photopheresis: A hypothesis‐generating data review of device settings and performance2
Botulism mimicking Guillain‐Barre syndrome: The question of plasma exchange in an unusual case of acute paralysis2
Legendary Case of Factitious Disorder Presenting as ‘Sickle Cell Disease’ Creates Challenges for All Medical Specialties2
Issue Information2
Successful stem cell collection for atypical teratoid rhabdoid tumor in an extremely low‐body weight child: A case report2
Francis S. Morrison MD—Tribute to an apheresis leader2
2
Successful Use of a Midline Catheter for Leukapheresis in Patients Undergoing Collection for Immune Effector Cell Therapy, Donor Lymphocyte Infusion, and Hematopoietic Progenitor Cell Collection2
Effects of central catheter recirculation during extracorporeal photopheresis2
The first reported use of red blood cell exchange to treat hemoglobin Evans with secondary methemoglobinemia2
1
Lack of defined apheresis collection criteria in publicly available CAR‐T cell clinical trial descriptions: Comprehensive review of over 600 studies1
Investigation on the feasibility of large‐volume autologous red blood cells donation: A pilot trial in a small cohort of Chinese1
Therapeutic plasma exchange and dextran‐sulfate plasma adsorption as extracorporeal treatments of extremely preterm preeclampsia with fetal growth restriction1
Peripheral blood stem cells collection by apheresis in very low‐weight children with malignant diseases—A single center experience1
Prospective, open‐label, multicenter clinical study to assess the performance of a new donation system for the collection of source plasma1
Baseline inflammation indexes and neutrophil‐to‐LDH ratio for prediction of the first mobilization failure without plerixafor‐based regimens in multiple myeloma and lymphoma patients: A sin1
Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy1
Benchmarking the centralized urgent plasma exchange service for patients admitted with a diagnosis of suspected acquired thrombotic thrombocytopenic purpura at a large healthcare system1
Analysis of 52 240 source plasma donors of convalescent COVID‐19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation1
The report from ASFA COVID‐19 taskforce: Considerations and prioritization on apheresis procedures during the SARS‐CoV‐2 coronavirus disease (COVID‐19) pandemic1
Apheresis medicine in the era of advanced telehealth technologies: An American Society for Apheresis position paper part II: Principles of apheresis medical practice in a 21st century electronic medic1
Ethylene oxide‐type hypersensitivity reactions in G‐CSF mobilized, peripheral blood hematopoietic progenitor cell donors and review1
A nomogram prediction of citrate reaction during mononuclear cell collection in solid tumor patients1
Therapeutic plasma exchange in refractory Susac's syndrome: A brief report1
Therapeutic plasma exchange as adjunct therapy for bullous pemphigoid1
Therapeutic leukocytapheresis for leukostasis in chronic lymphocytic leukemia: A case report and literature review1
Implementation of Ultrasound‐Guided Cannulation Training Across Eight NHSBT Therapeutic Apheresis Units in England1
Prevalence of baseline hypocalcemia and symptomatic hypocalcemia during leukapheresis1
Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation1
Therapeutic plasmapheresis for the treatment of thyrotoxicosis: A retrospective multi‐center study1
Comparison of centrifugal and membrane filtration modalities on therapeutic plasma exchange1
Revisiting the benefits of isovolemic hemodilution red cell exchange for sickle cell disease1
Safe peripheral blood stem cell collection in patients less than 10 kg: A single‐center review1
Therapeutic plasma exchange provides native liver survival benefit in children with acute liver failure: A propensity score‐matched analysis1
A case of severe DRESS syndrome treated with therapeutic plasma exchange and intravenous immunoglobulin therapy1
“Plasma exchange in a bottle”: An overview of efgartigimod for apheresis practitioners1
The first pediatric case of hemophagocytic lymphohistiocytosis secondary to Crimean‐Congo haemorrhagic fever successfully treated with therapeutic plasma exchange accompanying ribavirin and1
Successful treatment with immunoadsorption therapy in four patients with severe and refractory anti‐N‐methyl‐D‐aspartate receptor encephalitis1
1
Issue Information1
Immunogenic and immunotolerogenic effects of extracorporeal photopheresis in high immunological risk kidney recipients. A single center case series1
Telapheresis: A new paradigm for “saw and evaluated”1
Tolerance and complications of therapeutic plasma exchange by centrifugation: A single center experience1
Fractionated plasma separation and adsorption integrated with continuous veno‐venous hemofiltration in patients with acute liver failure: A single center experience from China1
1
Total nucleated cell dose in graft is a better prognostic factor for survival in pediatric patients transplanted with bone marrow compared to CD34+, CD3+, or total mononuclear ce1
Failure of double filtration plasmapheresis to treat severe pemphigus vulgaris: A case report1
Issue Information1
Issue Information1
A single center retrospective study: Comparison between centrifugal separation plasma exchange with ACD‐A and membrane separation plasma exchange with heparin on acute liver failure and acu1
Favorable recovery profiles and good reliability among youngest unrelated stem cell donors supports lowering the minimum donor registration age1
Immunogenicity of SARSCoV‐2 vaccines in patients treated with chronic double filtration plasmapheresis1
Issue Information1
Efficacy of peripheral arterial access for peripheral blood stem cells collection1
Comparison of hematopoietic progenitor cell collection using different inlet flow rates with the Fenwal Amicus1
In situ off‐line extracorporeal photopheresis conducted in a real‐life situation at a Hemobiotherapy Department in France: A comparison of costs vs on‐line procedure1
1
1
Issue Information1
Comment on “Treatment of comatose patient from cyclobenzaprine overdose with therapeutic plasma exchange”1
Therapeutic plasma‐exchange improves short‐term, but not long‐term, outcomes in patients with acute‐on‐chronic liver failure: A propensity score‐matched analysis1
Treatment of antibody‐mediated rejection with double‐filtration plasmapheresis, low dose IVIg plus rituximab after kidney transplantation1
Severely obese patients and the total blood volume dilemma focus group at the 2022 annual American Society for Apheresis meeting in Philadelphia1
Manipulating the complement system via Therapeutic plasmapheresis: Is there any therapeutic role?1
1
Novel use of a midline catheter for therapeutic and donor apheresis in children and adults1
Issue Information1
0.022785902023315